Literature DB >> 3413201

The effect of chronic cocaine on self-stimulation train-duration thresholds.

R A Frank1, S Martz, T Pommering.   

Abstract

The effect of chronic cocaine treatment on brain stimulation reward was assessed by examining self-stimulation train-duration thresholds. Following a predrug, saline injection period, cocaine hydrochloride (10 or 15 mg/kg) was injected (IP) across 18 consecutive days of testing. Cocaine lowered thresholds across the entire period of drug administration, with the magnitude of cocaine's effect remaining stable during this time. The subjects returned to predrug, saline levels during a postdrug test conducted immediately following chronic cocaine treatment. In a final attempt to modify cocaine's effects, the subjects received 25 mg/kg cocaine HCl three times/day for three consecutive days. Subsequent testing at the original dosage levels revealed no change in the magnitude of cocaine's effect. It was concluded that cocaine's effect on brain stimulation reward does not show tolerance or sensitization with chronic use. Similar effects have been reported for morphine and amphetamine's effect on brain stimulation reward.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3413201     DOI: 10.1016/0091-3057(88)90199-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

Review 1.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

2.  The rewarding and locomotor-sensitizing effects of repeated cocaine administration are distinct and separable in mice.

Authors:  Thorfinn T Riday; Barry E Kosofsky; C J Malanga
Journal:  Neuropharmacology       Date:  2011-12-16       Impact factor: 5.250

3.  Withdrawal from chronic cocaine administration induces deficits in brain reward function in C57BL/6J mice.

Authors:  Astrid K Stoker; Athina Markou
Journal:  Behav Brain Res       Date:  2011-05-05       Impact factor: 3.332

4.  Central leptin signaling transmits positive valence.

Authors:  Amber L Alhadeff; Sineadh M Conway; Zhi Yi Ong; Hallie S Wald; Mitchell F Roitman; Harvey J Grill
Journal:  Brain Res       Date:  2019-09-09       Impact factor: 3.252

5.  Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats.

Authors:  Paul J Kenny; Benjamin Boutrel; Fabrizio Gasparini; George F Koob; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2004-12-16       Impact factor: 4.530

6.  The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration and cue-induced cocaine-seeking and counteracts cocaine-induced enhancement of brain reward function in rats.

Authors:  Xinchun Jin; Svetlana Semenova; Li Yang; Robert Ardecky; Douglas J Sheffler; Russell Dahl; P Jeffrey Conn; Nicholas D P Cosford; Athina Markou
Journal:  Neuropsychopharmacology       Date:  2010-06-16       Impact factor: 7.853

7.  Phencyclidine-induced potentiation of brain stimulation reward: acute effects are not altered by repeated administration.

Authors:  W A Carlezon; R A Wise
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Effects of the neuroactive steroid allopregnanolone on intracranial self-stimulation in C57BL/6J mice.

Authors:  A Leslie Morrow; C J Malanga; Eric W Fish; Buddy J Whitman; Jeff F DiBerto; J Elliott Robinson
Journal:  Psychopharmacology (Berl)       Date:  2014-05-09       Impact factor: 4.530

9.  Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds.

Authors:  R A Wise; E Munn
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

10.  At what stage of neural processing does cocaine act to boost pursuit of rewards?

Authors:  Giovanni Hernandez; Yannick-André Breton; Kent Conover; Peter Shizgal
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.